FibroBiologics Inc. — Form C-U (Regulation Crowdfunding)
FibroBiologics Inc. of HOUSTON, TX filed a Form C-U (Regulation Crowdfunding) with the SEC on 2023-04-11. Target raise $10K, up to $5.0M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2023-04-11
- Form: C-U
- Accession: 0001665160-23-000576
- Target amount: $10K
- Maximum amount: $5.0M
- Security type: Other
- Securities offered: 5,917
- Price: $1.6900
- Deadline: 2023-04-04
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0001958777
- Website: https://fibrobiologics.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2021-04-08
- Address: 455 E. MEDICAL CENTER BLVD, SUITE 300, HOUSTON, TX, 77598
- Employees: 5
Financials (as filed)
- Total assets (most recent): $468K
- Cash (most recent): $407K
- Net income (most recent): $-1.6M
- Net income (prior): $-1.2M
- Short-term debt: $1.8M
People (7)
| Name | Role | Location |
|---|
| Matthew Link | Director | Houston, TX |
| Stacy Coen | Director | Houston, TX |
| Victoria Niklas | Director | Houston, TX |
| Richard Cilento | Director | Toronto, A6 |
| Peter O'Heeron | Chairman/Founder/CEO | Tucson, AZ |
| Peter O'Heeron | President, CEO and Chairman of the Board | Tucson, AZ |
| Mark Andersen | CFO | Houston, TX |
Reg CF filing history (5)
More